Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats. - Wikidata - awgldk - TriplyDB

Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats.

Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats.

http://www.wikidata.org/entity/Q37198943

about

Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats.Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.

P2860

Q33364402-DA3702E0-35FB-46EB-A2BB-200186349662 Q34698101-ED2B46A5-74A8-499B-9A68-93C297313CB5

P2860

Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats.

http://www.wikidata.org/entity/Q37198943

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of adverse effects ...... mical analytes in wistar rats.

@en

Evaluation of adverse effects ...... mical analytes in wistar rats.

@nl

type

label

Evaluation of adverse effects ...... mical analytes in wistar rats.

@en

Evaluation of adverse effects ...... mical analytes in wistar rats.

@nl

prefLabel

Evaluation of adverse effects ...... mical analytes in wistar rats.

@en

Evaluation of adverse effects ...... mical analytes in wistar rats.

@nl

P1433

Q37198943-A13593DB-0B6E-4523-B6F6-1D55780668F1

P1476

Q37198943-67C2256B-1214-4527-B19F-9FF3C5353A53

P2093

Q37198943-3B338720-4F68-42B8-B8EF-7468654F8848

Q37198943-42AE11F3-373A-40EA-9244-92337E0A742B

Q37198943-59A9F4A0-E8E4-498E-8C96-FFF8C7DB1D58

Q37198943-99F3ED4D-3CC0-4D2A-A0F2-AC54068D2180

Q37198943-A7B7C646-C87C-4404-9B9C-C9CD88DE3A6A

P2860

Q37198943-057AACEB-13D5-4F68-82E7-020EF0E3B6C3

Q37198943-1C86FCE1-B8CC-4E26-8733-DCFEADF3BF91

Q37198943-1F4A8645-5879-4575-BD30-F58B415EEC89

Q37198943-2FB7FCA6-4483-4C81-978D-00F459988E2B

Q37198943-34F95A44-C063-4CE8-A1FC-C36E3588F620

Q37198943-48B7E7A9-F09D-48F6-9CFE-02E2F6191F15

Q37198943-4DDBAE75-04FF-4FD3-9E37-35A354D518D0

Q37198943-5F987787-FA5F-43EA-AA22-6C7CA641E246

Q37198943-67B92FBC-DFA3-4565-B225-C7DD6973501C

Q37198943-6DFD8CCC-1232-4F8E-85D4-CF57A0A3BDDA

P304

Q37198943-E5F7E18C-A39D-432D-9CC7-2864A620351F

P31

Q37198943-2CA0AD21-7172-45E7-BA76-A7F1B8E901B5

P356

Q37198943-583C4E92-02C3-456E-AA39-ABD6AF7DCDCB

P433

Q37198943-6E454B21-6ACC-4EC0-A8E2-0606AD87C8BA

P478

Q37198943-20B54DDE-C5CC-4154-9644-B7A13BFF4B2E

P577

Q37198943-F25C0E2E-9585-4548-A78F-7ACC008A9BDF

P698

Q37198943-8A44E79D-EED5-431C-8BA6-5AADC4CA6111

P932

Q37198943-25F9C39B-F6EE-42EF-B1B3-984CCBD4A254

P356

0971-6580.117261

P1433

Toxicology International

P1476

Evaluation of adverse effects ...... mical analytes in wistar rats.

@en

P2093

Hardik Dodiya

http://www.w3.org/2001/XMLSchema#string

Mukul Jain

http://www.w3.org/2001/XMLSchema#string

Rajesh Sundar

http://www.w3.org/2001/XMLSchema#string

Sunita Goswami

http://www.w3.org/2001/XMLSchema#string

Vijay Kale

http://www.w3.org/2001/XMLSchema#string

P2860

Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases.

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.

Statin-associated myopathy with normal creatine kinase levels.

Statin-associated myopathy.

Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction

Statin-fibrate combination therapy.

Statin safety: a systematic review.

Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature.

Should angiotensin II receptor blockers and statins be combined?

Regional variations in cardiovascular risk factors in India: India heart watch

P304

170-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0971-6580.117261

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24082511

http://www.w3.org/2001/XMLSchema#string

P932

3783684

http://www.w3.org/2001/XMLSchema#string